ZA200900043B - Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components - Google Patents

Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components

Info

Publication number
ZA200900043B
ZA200900043B ZA200900043A ZA200900043A ZA200900043B ZA 200900043 B ZA200900043 B ZA 200900043B ZA 200900043 A ZA200900043 A ZA 200900043A ZA 200900043 A ZA200900043 A ZA 200900043A ZA 200900043 B ZA200900043 B ZA 200900043B
Authority
ZA
South Africa
Prior art keywords
clathrin
materials
methods
pathway components
detecting fragments
Prior art date
Application number
ZA200900043A
Other languages
English (en)
Inventor
Cary D Austin
David A Lawrence
Avi Ashkenazi
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA200900043B publication Critical patent/ZA200900043B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA200900043A 2006-06-20 2007-06-20 Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components ZA200900043B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81495506P 2006-06-20 2006-06-20

Publications (1)

Publication Number Publication Date
ZA200900043B true ZA200900043B (en) 2010-03-31

Family

ID=38834096

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200900043A ZA200900043B (en) 2006-06-20 2007-06-20 Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components

Country Status (14)

Country Link
US (1) US8198033B2 (fr)
EP (1) EP2044434B1 (fr)
JP (1) JP5222845B2 (fr)
KR (1) KR101433971B1 (fr)
CN (1) CN101535805B (fr)
AU (1) AU2007261405B2 (fr)
BR (1) BRPI0712629C1 (fr)
CA (1) CA2655460C (fr)
IL (1) IL195973A (fr)
MX (1) MX2008016170A (fr)
NZ (1) NZ574009A (fr)
RU (1) RU2450273C2 (fr)
WO (1) WO2007149486A2 (fr)
ZA (1) ZA200900043B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5133842B2 (ja) * 2008-10-14 2013-01-30 国立大学法人 千葉大学 癌が疑われる患者または癌患者由来の組織の癌部と非癌部との判別方法およびそれに用いる判別試薬
RU2508542C1 (ru) * 2012-07-16 2014-02-27 Полина Михайловна Шварцбурд Экспресс-способ определения риска злокачественности клеток
US11299528B2 (en) 2014-03-11 2022-04-12 D&D Pharmatech Inc. Long acting TRAIL receptor agonists for treatment of autoimmune diseases
US11007251B2 (en) 2015-12-17 2021-05-18 The Johns Hopkins University Ameliorating systemic sclerosis with death receptor agonists
AU2017248264B2 (en) 2016-04-07 2020-01-30 The Johns Hopkins University Compositions and methods for treating pancreatitis and pain with death receptor agonists
GB201615842D0 (en) 2016-09-16 2016-11-02 Ucl Business Plc Cell death biomarker

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935801A (en) * 1996-03-29 1999-08-10 Dana-Farber Cancer Institute Monoclonal antibody that detects apoptotic antigen
EP1077724A2 (fr) * 1998-04-17 2001-02-28 The University Of Vermont Methodes et produits concernant les interactions metaboliques dans les maladies
WO2000017648A1 (fr) * 1998-09-24 2000-03-30 Promega Corporation Anticorps marqueurs d'apoptose et methodes d'utilisations
WO2002052032A1 (fr) * 2000-12-22 2002-07-04 Chugai Seiyaku Kabushiki Kaisha Procede servant a mesurer la mort cellulaire de cellules ciblees
US6797677B2 (en) 2002-05-30 2004-09-28 Afton Chemical Corporation Antioxidant combination for oxidation and deposit control in lubricants containing molybdenum and alkylated phenothiazine
CA2528669A1 (fr) * 2003-06-09 2005-01-20 The Regents Of The University Of Michigan Compositions et methodes de traitement et de diagnostic du cancer

Also Published As

Publication number Publication date
CA2655460A1 (fr) 2007-12-27
BRPI0712629C1 (pt) 2021-07-27
AU2007261405B2 (en) 2013-02-14
EP2044434A2 (fr) 2009-04-08
JP5222845B2 (ja) 2013-06-26
JP2009541741A (ja) 2009-11-26
RU2009101512A (ru) 2010-07-27
MX2008016170A (es) 2009-02-03
KR101433971B1 (ko) 2014-08-25
KR20090024795A (ko) 2009-03-09
BRPI0712629A2 (pt) 2012-10-23
RU2450273C2 (ru) 2012-05-10
CA2655460C (fr) 2014-05-20
CN101535805A (zh) 2009-09-16
EP2044434B1 (fr) 2015-11-18
IL195973A (en) 2011-05-31
AU2007261405A1 (en) 2007-12-27
WO2007149486A3 (fr) 2008-03-20
US20110244473A1 (en) 2011-10-06
WO2007149486A2 (fr) 2007-12-27
BRPI0712629B1 (pt) 2018-07-17
IL195973A0 (en) 2009-09-01
BRPI0712629B8 (pt) 2018-09-25
NZ574009A (en) 2012-01-12
US8198033B2 (en) 2012-06-12
CN101535805B (zh) 2014-02-12

Similar Documents

Publication Publication Date Title
ZA201004914B (en) Compositions and methods of detecting tiabs
EP2430446A4 (fr) Procédés et compositions pour une détection d'analyte
GB0616376D0 (en) Raman analysis of tissue
GB0725089D0 (en) Composition and method for detection of demineralisation
ZA201001878B (en) Improved detection of mage-a-expression
SI2297585T1 (sl) Detekcija uživanja konoplje
ZA200704159B (en) Method for analysis of pellet-cladding interaction
EP2142926A4 (fr) Compositions et procédés de détection
GB2446238B (en) Apparatus for ionization of samples
IL187203A0 (en) Matrix for detection/ analysis of residues
ZA200904558B (en) Detection of analytes
EP2069384A4 (fr) Fragments de biomarqueurs pour la détection du bnp humain
IL195973A0 (en) Methods and materials for observing apoptosis
GB0701599D0 (en) Method of detection
ZA201007010B (en) Rapid detection of mycobateria
GB0903848D0 (en) Methods and compositions for highly sensitive detection of molecules
EP2121042A4 (fr) Composés et méthodes de détection de cellules
EP2180062A4 (fr) Procédé de détection d'une substance cible
GB0613182D0 (en) Method of detection
GB0613284D0 (en) Detection of substances
GB0605557D0 (en) Method Of Detection
GB2444777B (en) Detection of radiation
TWI319085B (en) Apparatus for measuring dimensions of particles
GB0616166D0 (en) Methods of and apparatus for generating multiple samples of materials
EP2180063A4 (fr) Procédé de détection d'une substance cible